News

Kinney Drugs names SVP pharmacy procurement

BY Antoinette Alexander

GOUVERNEUR, N.Y. — Kinney Drugs, which operates 91 stores in central and northern New York and Vermont, has announced the recent promotion of 30-year company veteran Owen Halloran to SVP pharmacy procurement.

As SVP pharmacy procurement, Halloran is responsible for overseeing all pharmaceutical purchasing for Kinney Drugs retail, mail-order and institutional pharmacy. Halloran has led the pharmacy purchasing department since 1996 and third-party contracting since 1999. He began his career with Kinney Drugs in 1978 as a staff pharmacist, and later served in several management positions, including his recent position of VP professional services. Halloran serves as a board member on the Kinney Drugs Foundation and the Canton-Potsdam Hospital.

"The knowledge and experience of Owen Halloran complement the Kinney Drugs mission of providing the highest-quality pharmacy, health and retail services to the communities we serve," stated Bridget-ann Hart, president and COO of Kinney Drugs. "We will continue to benefit from his leadership and look forward to his contributions as we continue building our employee-owned company."

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Does increased purchase frequency translate into healthier bottom lines?

BY Michael Johnsen

WHAT IT MEANS AND WHY IT’S IMPORTANT — Purchase frequency in the drug channel is up 6.7%. Sounds good, right? More shoppers buying more often — that’s the end-game, isn’t it? Except not so fast, because the real question is whether or not higher frequency of purchases actually translates into greater revenue streams. And, given the rocky road that America’s now-you-see-it-now-you-don’t recovery has traveled of late, more shoppers may in fact be buying more often, but they actually may be spending less. 

(THE NEWS: Report: Purchase frequency in drug channel up 6.7%. For the full story, click here.)

The underlying reason more of those shoppers are taking trips to their local drug store more often is because of convenience. And pharmacy, with its smaller boxes, extended hours, drive-through windows and the recent trend toward serving up more fresh food, has convenience in spades. That’s what those fill-in trips represent. Even if the average consumer brings a smaller market basket to the checkstand, if there are more consumers carrying those market baskets in the store to begin with, that still represents a very healthy revenue stream.

But the concern is if or when the U.S. economy free falls back into a full-blown recession. That may not be too long off with Congress’ very-public partisan battle over the debt ceiling and the growing government-debt concerns across Western Europe that are fostering so much volatility on Wall Street — the Dow dropped 500 points just last Thursday. The concern is if or when U.S. companies revert to more-conservative growth strategies that potentially could derail any kind of job growth — there were only 117,000 more jobs reported in July, the most in two months, and unemployment still stands at 9.1%. The concern is if or when consumers become anxious over their future again, and value begins trumping convenience as a result.

Take the growing consumer interest in extreme couponing, for instance. The danger isn’t so much the you’ve-got-to-be-kidding-me extremists who dumpster dive for deals and spend hours upon hours plotting how to get $1 in merchandise by spending only 15 cents. It’s the legions of average consumers those extremists inspire.

Overall redemption volume in the U.S. grew 3.1% to 3.3 billion consumer-packaged-goods coupons in 2010, according to NCH, a firm that provides business solutions for the redemption, settlement and analysis of promotional offers. In 2010, 78.3% of consumers reported using coupons regularly, up 14.7 share points from pre-recession levels, and one-third of the respondents in NCH’s annual consumer survey said that they used more coupons in 2010 than the prior year. In total, 2010 consumer CPG coupon usage added up to $3.7 billion of savings in the United States, an increase of $200 million over the prior year.

Over the course of the first half of 2011, redemption volume increased 26% across drug stores; 11.2% across other store types, including dollars stores up 11.2%; and 10.4% across mass.

So, will the momentum behind increased purchase frequency translate into a healthier bottom line, even if the consumer is spending less? If the U.S. economy is standing at the precipice of the second plunge of a double-dip recession, what does that mean for retailers? The winners in all of this will be the retailers who successfully communicate both value and convenience. With the number of drug store retailers enhancing loyalty card programs and increasing consumer touchpoints through technology, that means those winners very well could come out of the drug channel.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Pharmacy professor to assist in review of ReachRx protocols and initiatives for Armada

BY Alaric DeArment

FLORHAM PARK, N.J. — Specialty pharmacy services company Armada Health Care has enlisted a New York pharmacy professor to assist in the review of developed clinical protocols and medication assessment tools, Armada said Monday.

Armada said Danielle Ezzo, a professor of pharmacy at St. John’s University of Pharmacy and Allied Health Professions in the New York borough of Queens, would assist in the review for protocols and initiatives supported by Armada’s ReachRx Online Therapy Management System, which includes 15 disease states ranging from HIV and AIDS to cancer.

"Armada is pleased to engage the clinical expertise of a clinical pharmacy practice faculty member from St. John’s University," Armada CEO Lawrence Irene said. "Dr. Ezzo’s clinical expertise will allow us to continue to deliver the highest quality web-based therapy management applications for our member pharmacies to effectively and efficiently manage patient protocols for specialty patients on complex medication therapies. Among its many benefits, the ReachRX OTM tool tracks adherence and helps increase patient compliance, which in turn benefits our partners in pharma and biotech drug manufacturing."

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES